HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Jianguo Xiao Selected Research
Jianguo Xiao Research Topics
Disease
5
Neoplasms (Cancer)
01/2016 - 09/2007
4
Ovarian Neoplasms (Ovarian Cancer)
01/2016 - 05/2009
3
Carcinoma (Carcinomatosis)
01/2016 - 09/2007
1
Cutaneous Fistula
01/2021
1
Hemorrhage
01/2021
1
Intestinal Fistula
01/2021
1
Pancreatitis
01/2021
1
Multiple Organ Failure (MODS)
01/2021
1
Exocrine Pancreatic Insufficiency
01/2021
1
Critical Illness (Critically Ill)
01/2019
1
Squamous Cell Neoplasms (Squamous Cell Cancer)
06/2012
1
Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2009
1
Carcinogenesis
01/2009
1
Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2009
1
Uterine Cervical Dysplasia
09/2007
1
Mental Disorders (Mental Disorder)
08/2004
Drug/Important Bio-Agent (IBA)
2
Saponins
IBA
04/2014 - 08/2012
2
formosanin C
IBA
04/2014 - 08/2012
2
Cyclin-Dependent Kinase Inhibitor p16
IBA
06/2012 - 09/2007
2
Tumor Suppressor Protein p14ARF (p14ARF)
IBA
06/2012 - 09/2007
1
Metoclopramide (Reglan)
FDA Link
Generic
01/2019
1
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
01/2016
1
NF-kappa B (NF-kB)
IBA
01/2016
1
Mitogen-Activated Protein Kinases
IBA
01/2016
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
04/2014
1
polyphyllin D
IBA
05/2009
1
Tyrosine Kinase Inhibitors
IBA
01/2009
1
Sirolimus (Rapamycin)
FDA Link
01/2009
1
ErbB Receptors (EGF Receptor)
IBA
01/2009
1
Erlotinib Hydrochloride (CP 358,774)
FDA Link
01/2009
1
TOR Serine-Threonine Kinases
IBA
01/2009
1
Proteins (Proteins, Gene)
FDA Link
09/2007
Therapy/Procedure
2
Therapeutics
05/2009 - 01/2009
1
Minimally Invasive Surgical Procedures
01/2021
1
Length of Stay
01/2021
1
Intravenous Injections
01/2019
1
Enteral Nutrition (Feeding, Tube)
01/2019
1
Nutritional Support (Artificial Feeding)
01/2019
1
Chinese Traditional Medicine (Traditional Chinese Medicine)
05/2009
1
Drug Therapy (Chemotherapy)
01/2009
1
Aftercare (After-Treatment)
08/2004